Watercress Research, founded in 2019, is a pioneering entity in the Health Care and Pharmaceutical industries, based in the United Kingdom. With a unique focus on discovering the pharmaceutical and nutraceutical properties of the watercress plant, its innovative approach is encapsulated in its slogan: "A research company discovering the pharmaceutical and nutraceutical effects of the watercress plant."
In its short span since inception, Watercress Research has already secured a Seed Round investment as of 01 January 2022, with contributions from investors like QantX. As an emerging player in an increasingly health-conscious world, the company is poised to leverage natural plant advantages, offering potential for substantive innovation in both pharmaceutical solutions and dietary supplements. With growing investor interest, its trajectory suggests promising opportunities for returns within this niche market.